Shizane's Accounts

[Shizane]

EVENTS: MSTX

Mast Therapeutics (MSTX $0.41) has completed or is in the process of completing these events by the end of the year - into the beginning of 2014. Thusly there should be an appreciation in the value of the stock into possibly the mid $0.60s were the warrants can be exercised and definitely above $0.50 (price of public offering).

MAST THERAPEUTICS PRICES PUBLIC OFFERING OF UNITS

EVENTS:

Report data from tQT/QTc Study

Q3-Completed>>>MAST THERAPEUTICS REPORTS RESULTS FROM CLINICAL QT STUDY OF MST-188


Submit Applications for U.S. Government Funding for Phase 2 Study in Resuscitation of Shock following Major Trauma

Q3-2013

Request Orphan Designation for MST-188 for ALI in U.S.

Q3-2013

Initiate Nonclinical Proof-of-Concept Study in Heart Failure

Q3-2013

Open First Ex-U.S. Clinical Site in Phase 3 Study

Q4-2013

Initiate Phase 2 Study in ALI

Q4 2013/Q1 2014